Vyndaqel Likely to Treat FAP Linked to Mutation Common in Asians, Lab Study Suggests
Vyndaqel (tafamidis) increases the stability of the transthyretin protein and may help people with familial amyloidosis polyneuropathy (FAP) carrying a TTR gene mutation common in Asian populations, an early study  from Taiwan suggests. …